Ignite Creation Date:
2025-12-24 @ 4:31 PM
Ignite Modification Date:
2026-01-04 @ 3:41 AM
Study NCT ID:
NCT05111366
Status:
UNKNOWN
Last Update Posted:
2022-05-04
First Post:
2021-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TQB2450 Plus Anlotinib as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Resection
Sponsor:
Xianhai Mao
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-06
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-05-20
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-27
First Submit QC Date:
None
Study First Post Date:
2021-11-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-28
Last Update Post Date:
2022-05-04
Last Update Post Date Type:
ACTUAL